BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 27225517)

  • 1. 18-kDa translocator protein ligand
    Hellberg S; Silvola JMU; Kiugel M; Liljenbäck H; Savisto N; Li XG; Thiele A; Lehmann L; Heinrich T; Vollmer S; Hakovirta H; Laine VJO; Ylä-Herttuala S; Knuuti J; Roivainen A; Saraste A
    J Nucl Cardiol; 2017 Jun; 24(3):862-871. PubMed ID: 27225517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Positron Emission Tomography Imaging of Macrophages in Atherosclerosis with
    Hellberg S; Liljenbäck H; Eskola O; Morisson-Iveson V; Morrison M; Trigg W; Saukko P; Ylä-Herttuala S; Knuuti J; Saraste A; Roivainen A
    Contrast Media Mol Imaging; 2018; 2018():9186902. PubMed ID: 29950954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type 2 diabetes enhances arterial uptake of choline in atherosclerotic mice: an imaging study with positron emission tomography tracer ¹⁸F-fluoromethylcholine.
    Hellberg S; Silvola JM; Kiugel M; Liljenbäck H; Metsälä O; Viljanen T; Metso J; Jauhiainen M; Saukko P; Nuutila P; Ylä-Herttuala S; Knuuti J; Roivainen A; Saraste A
    Cardiovasc Diabetol; 2016 Feb; 15():26. PubMed ID: 26852231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of age, diet, and type 2 diabetes on the development and FDG uptake of atherosclerotic plaques.
    Silvola JM; Saraste A; Laitinen I; Savisto N; Laine VJ; Heinonen SE; Ylä-Herttuala S; Saukko P; Nuutila P; Roivainen A; Knuuti J
    JACC Cardiovasc Imaging; 2011 Dec; 4(12):1294-301. PubMed ID: 22172786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of alphavbeta3 integrin-targeted positron emission tomography tracer 18F-galacto-RGD for imaging of vascular inflammation in atherosclerotic mice.
    Laitinen I; Saraste A; Weidl E; Poethko T; Weber AW; Nekolla SG; Leppänen P; Ylä-Herttuala S; Hölzlwimmer G; Walch A; Esposito I; Wester HJ; Knuuti J; Schwaiger M
    Circ Cardiovasc Imaging; 2009 Jul; 2(4):331-8. PubMed ID: 19808614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of hypoxia by [18F]EF5 in atherosclerotic plaques in mice.
    Silvola JM; Saraste A; Forsback S; Laine VJ; Saukko P; Heinonen SE; Ylä-Herttuala S; Roivainen A; Knuuti J
    Arterioscler Thromb Vasc Biol; 2011 May; 31(5):1011-5. PubMed ID: 21372297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positron emission tomography imaging of the 18-kDa translocator protein (TSPO) with [18F]FEMPA in Alzheimer's disease patients and control subjects.
    Varrone A; Oikonen V; Forsberg A; Joutsa J; Takano A; Solin O; Haaparanta-Solin M; Nag S; Nakao R; Al-Tawil N; Wells LA; Rabiner EA; Valencia R; Schultze-Mosgau M; Thiele A; Vollmer S; Dyrks T; Lehmann L; Heinrich T; Hoffmann A; Nordberg A; Halldin C; Rinne JO
    Eur J Nucl Med Mol Imaging; 2015 Mar; 42(3):438-46. PubMed ID: 25412766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amyloid-Targeting PET Tracer [
    Hellberg S; Silvola JMU; Liljenbäck H; Kiugel M; Eskola O; Hakovirta H; Hörkkö S; Morisson-Iveson V; Hirani E; Saukko P; Ylä-Herttuala S; Knuuti J; Saraste A; Roivainen A
    Molecules; 2019 Mar; 24(6):. PubMed ID: 30893771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uptake of 11C-choline in mouse atherosclerotic plaques.
    Laitinen IE; Luoto P; Någren K; Marjamäki PM; Silvola JM; Hellberg S; Laine VJ; Ylä-Herttuala S; Knuuti J; Roivainen A
    J Nucl Med; 2010 May; 51(5):798-802. PubMed ID: 20395326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploiting Glutamine Consumption in Atherosclerotic Lesions by Positron Emission Tomography Tracer (2
    Palani S; Miner MWG; Virta J; Liljenbäck H; Eskola O; Örd T; Ravindran A; Kaikkonen MU; Knuuti J; Li XG; Saraste A; Roivainen A
    Front Immunol; 2022; 13():821423. PubMed ID: 35145523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of [
    Kiugel M; Hellberg S; Käkelä M; Liljenbäck H; Saanijoki T; Li XG; Tuomela J; Knuuti J; Saraste A; Roivainen A
    Molecules; 2018 Dec; 23(12):. PubMed ID: 30513758
    [No Abstract]   [Full Text] [Related]  

  • 12. [18F]fluorodeoxyglucose uptake in atherosclerotic plaques is associated with reduced coronary flow reserve in mice.
    Uotila S; Silvola JM; Saukko P; Nuutila P; Heinonen SE; Ylä-Herttuala S; Roivainen A; Knuuti J; Saraste A
    J Ultrasound Med; 2014 Nov; 33(11):1941-8. PubMed ID: 25336481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Somatostatin Receptor 2-Targeting PET Tracers in the Detection of Mouse Atherosclerotic Plaques.
    Rinne P; Hellberg S; Kiugel M; Virta J; Li XG; Käkelä M; Helariutta K; Luoto P; Liljenbäck H; Hakovirta H; Gardberg M; Airaksinen AJ; Knuuti J; Saraste A; Roivainen A
    Mol Imaging Biol; 2016 Feb; 18(1):99-108. PubMed ID: 26122428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Translocator protein localises to CD11b
    Kopecky C; Pandzic E; Parmar A; Szajer J; Lee V; Dupuy A; Arthur A; Fok S; Whan R; Ryder WJ; Rye KA; Cochran BJ
    Atherosclerosis; 2019 May; 284():153-159. PubMed ID: 30913515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uptake of inflammatory cell marker [11C]PK11195 into mouse atherosclerotic plaques.
    Laitinen I; Marjamäki P; Någren K; Laine VJ; Wilson I; Leppänen P; Ylä-Herttuala S; Roivainen A; Knuuti J
    Eur J Nucl Med Mol Imaging; 2009 Jan; 36(1):73-80. PubMed ID: 18712383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular Imaging of Inflammation in a Mouse Model of Atherosclerosis Using a Zirconium-89-Labeled Probe.
    Ahmed M; Tegnebratt T; Tran TA; Lu L; Damberg P; Gisterå A; Tarnawski L; Bone D; Hedin U; Eriksson P; Holmin S; Gustafsson B; Caidahl K
    Int J Nanomedicine; 2020; 15():6137-6152. PubMed ID: 32884268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In Vivo PET Imaging of HDL in Multiple Atherosclerosis Models.
    Pérez-Medina C; Binderup T; Lobatto ME; Tang J; Calcagno C; Giesen L; Wessel CH; Witjes J; Ishino S; Baxter S; Zhao Y; Ramachandran S; Eldib M; Sánchez-Gaytán BL; Robson PM; Bini J; Granada JF; Fish KM; Stroes ES; Duivenvoorden R; Tsimikas S; Lewis JS; Reiner T; Fuster V; Kjær A; Fisher EA; Fayad ZA; Mulder WJ
    JACC Cardiovasc Imaging; 2016 Aug; 9(8):950-61. PubMed ID: 27236528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of atorvastatin and diet interventions on atherosclerotic plaque inflammation and [
    Hellberg S; Sippola S; Liljenbäck H; Virta J; Silvola JMU; Ståhle M; Savisto N; Metso J; Jauhiainen M; Saukko P; Ylä-Herttuala S; Nuutila P; Knuuti J; Roivainen A; Saraste A
    Atherosclerosis; 2017 Aug; 263():369-376. PubMed ID: 28457625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-specific binding of [18F]FDG to calcifications in atherosclerotic plaques: experimental study of mouse and human arteries.
    Laitinen I; Marjamäki P; Haaparanta M; Savisto N; Laine VJ; Soini SL; Wilson I; Leppänen P; Ylä-Herttuala S; Roivainen A; Knuuti J
    Eur J Nucl Med Mol Imaging; 2006 Dec; 33(12):1461-7. PubMed ID: 16845513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preclinical in vivo and in vitro comparison of the translocator protein PET ligands [
    Eberl S; Katsifis A; Peyronneau MA; Wen L; Henderson D; Loc'h C; Greguric I; Verschuer J; Pham T; Lam P; Mattner F; Mohamed A; Fulham MJ
    Eur J Nucl Med Mol Imaging; 2017 Feb; 44(2):296-307. PubMed ID: 27699720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.